Aster DM Healthcare appoints Purana H Deepti as Additional Director
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Rocuronium Bromide Injection is a neuromuscular blocking agent
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
Receives regulatory approval for its molecule ‘Selumetinib’ in India
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Subscribe To Our Newsletter & Stay Updated